Results 131 to 140 of about 2,068 (215)

Beyond Numbers: Uses and Value of In-Trial Interview Data for Regulatory and Health Technology Assessment (HTA) Decision Making. [PDF]

Patient
Dias-Barbosa C, Kimel M, Rolska-Wojcik P, Bailey K, Eseyin OR, Martin ML.   +5 more
europepmc   +1 more source

Reply to Gringras et al. Comment on "Paditz et al. The Pharmacokinetics, Dosage, Preparation Forms, and Efficacy of Orally Administered Melatonin for Non-Organic Sleep Disorders in Autism Spectrum Disorder During Childhood and Adolescence: A Systematic Review. <i>Children</i> 2025, <i>12</i>, 648". [PDF]

Children (Basel)
Paditz E, Renner B, Koch R, Schneider BM, Schlarb AA.   +4 more
europepmc   +1 more source

The Importance of Content Validity in Accredited Continuing Medical Education/Continuing Professional Development (CME/CPD). [PDF]

J CME
Schaefer R, Regnier K, Smith M, Elsayed E, Parsa-Parsi R, Stein J, Kloiber O, Griebenow R.   +7 more
europepmc   +1 more source

Genomic tests to guide management of breast cancer in Europe: regulation, reimbursement, adoption, and challenges. [PDF]

Future Oncol
Verrill M, Lux MP, Gligorov J, Geisler J, Duchnowska R, Elsberger B, Martin M.   +6 more
europepmc   +1 more source

Implementation of the EU's Health Technology Assessment regulation: where does existing methods guidance require concretization and what are the relevant methodological options? [PDF]

Int J Technol Assess Health Care
Goetz G, Schandelmaier S, Busse R, Wild C, Panteli D.   +4 more
europepmc   +1 more source

Health Technology Assessment Guidelines and Recommendations Across European Union Countries and the United Kingdom in Rare Disease and Paediatric Populations. [PDF]

Appl Health Econ Health Policy
Bártová A, Samek J, Pinheiro V, Říhová B, Santos JV.   +4 more
europepmc   +1 more source

Surrogate Endpoints for Overall Survival in Advanced Hepatocelluar Carcinoma in the Era of Immunotherapy: A Trial Level Meta-Analysis. [PDF]

Liver Cancer
Saleh Y, Baskurt Z, Farooq AR, Goodwin R, Knox J, O'Kane G, Chen EX.   +6 more
europepmc   +1 more source

Results of health technology assessments of orphan drugs in Germany-lack of added benefit, evidence gaps, and persisting unmet medical needs. [PDF]

Int J Technol Assess Health Care
Kranz P, McGauran N, Ünal C, Kaiser T.
europepmc   +1 more source

Navigating change: a comparative analysis of health technology assessment reforms across agencies - processes, drivers, and interdependencies. [PDF]

Int J Technol Assess Health Care
Kumar G, Radu P, Cubi-Molla P, Garau M, Bell E, Pan J, Gilardino R, Van Bavel J, Brandtmüller A, Nelson K, Goodall M.   +10 more
europepmc   +1 more source

A systematic literature review (SLR) on the adoption of artificial intelligence-assisted SLRS: implications for health technology assessments. [PDF]

Int J Technol Assess Health Care
Abogunrin S, Liu Y, Zerbini CH.
europepmc   +1 more source